Eurand drug delivery
This article was originally published in The Tan Sheet
Executive SummaryItalian firm launches AdvaTab fast dissolve technology for products that "dissolve rapidly in the mouth without the need for chewing or water." Tablets dissolve within 15-30 seconds for "convenience, compliance and, as a result, improved efficacy," company says. AdvaTab incorporates a proprietary external lubrication system and can be combined with Eurand's Microcaps taste-masking technology. Firm estimates worldwide sales of over $1 bil. for drugs with fast-dissolve technology; among Eurand's top-selling OTCs are acetaminophen, pseudoephedrine, ibuprofen...
You may also be interested in...
In an exclusive interview with Medtech Insight, Mark Leahey, president of the Medical Device Manufacturers Association (MDMA), said the previous four Medical Device User Fee negotiations with the US FDA have set a strong foundation for the industry and the next round of negotiations should focus on tweaking past deals that are already in place. See what MDMA's president, Mark Leahey, said about it here.
US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.
Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.